Advertisement
Research Article| Volume 446, 120585, March 15, 2023

Prevalence of autistic traits in functional neurological disorder and relationship to alexithymia and psychiatric comorbidity

Open AccessPublished:February 12, 2023DOI:https://doi.org/10.1016/j.jns.2023.120585

      Highlights

      • We report new evidence of high rates of autistic traits in a group with FND.
      • 40% of participants scored positive on the AQ-10.
      • 40% of patients also scored positive for alexithymia.

      Abstract

      Introduction

      In a cohort of adults with Functional Neurological Disorder (FND), we aim to:
      • 1)
        Report the prevalence of autistic traits and alexithymia.
      • 2)
        Report psychiatric comorbidity associated with autistic traits and alexithymia.
      • 3)
        Explore whether alexithymia mediates the association between autistic traits and comorbidity.

      Methods

      91 patients participating in a FND 5-week outpatient program completed baseline self-report questionnaires for total phobia, somatic symptom severity, attention deficit hyperactivity disorder (ADHD) and dyslexia. Patients were grouped by Autism Spectrum Quotient (AQ-10) score of <6 or ≥ 6 and compared for significant differences in tested variables. This analysis was repeated with patients grouped by alexithymia status. Simple effects were tested using pairwise comparisons. Multistep regression models tested direct relationships between autistic traits and psychiatric comorbidity scores, and mediation by alexithymia.

      Results

      36 patients (40%) were AQ-10 positive (scoring ≥6 on AQ-10). A further 36 patients (across AQ-10 positive and AQ-10 negative groups) (40%) screened positive for alexithymia. AQ-10 positive patients scored significantly higher for alexithymia, depression, generalised anxiety, social phobia, ADHD, and dyslexia. Alexithymia positive patients scored significantly higher for generalised anxiety, depression, somatic symptoms severity, social phobia, and dyslexia. Alexithymia score was found to mediate the relationship between autistic trait and depression scores.

      Conclusion

      We demonstrate a high proportion of autistic and alexithymic traits, in adults with FND. A higher prevalence of autistic traits may highlight a need for specialised communication approaches in FND management. Mechanistic conclusions are limited. Future research could explore links with interoceptive data.

      Keywords

      1. Introduction

      Functional Neurological Disorder (FND) and Autism Spectrum Disorder (ASD) are two conditions commonly seen in neuropsychiatric settings with potential for high levels of disability. Symptoms manifest through the nervous system and, in the case of FND, do not relate to underlying structural neurological pathology. Despite common features, very little work has explored ASD is adults with FND.

      1.1 Functional neurological disorder

      In FND neurological symptoms demonstrate clinical features incompatible with structural pathology, there is abnormal function a system that is capable of normal function [
      • Bennett K.
      • Diamond C.
      • Hoeritzauer I.
      • Gardiner P.
      • McWhirter L.
      • Carson A.
      • et al.
      A practical review of functional neurological disorder (FND) for the general physician.
      ].
      The current model of understanding focuses on strong ideas and expectations about a sensitising event (e.g., medical illness, physical trauma, psychophysiological events) alongside abnormal predictions of sensory data and body-focused attention [
      • Espay A.J.
      • Aybek S.
      • Carson A.
      • Edwards M.J.
      • Goldstein L.H.
      • Hallett M.
      • et al.
      Current concepts in diagnosis and treatment of functional neurological disorders.
      ]. Processing alterations reported in FND include limbic (amygdala) hyperactivation, excessive affective (autonomic) arousal and threat-related hypervigilance. There is also wider evidence in somatisation disorders of a higher prevalence of alexithymia and impaired interoception of bodily emotional responses, resulting in a reduced emotional awareness with limited integration of affective, cognitive and viscerosomatic experiences [
      • Tian J.
      • Gao X.
      • Yang L.
      Repetitive restricted behaviors in autism spectrum disorder: from mechanism to development of therapeutics.
      ].
      Psychiatric comorbidities are common in FND including depression, anxiety, panic disorder, personality disorders and obsessive compulsive personality disorders, as are functional somatic syndromes (such as irritable bowel, chronic fatigue and fibromyalgia) [
      • Bennett K.
      • Diamond C.
      • Hoeritzauer I.
      • Gardiner P.
      • McWhirter L.
      • Carson A.
      • et al.
      A practical review of functional neurological disorder (FND) for the general physician.
      ]. Common neurological comorbidities include epilepsy, migraine, and traumatic brain injury.

      1.2 Autism spectrum condition / disorder

      Autism Spectrum Disorder (ASD) is a neurodevelopmental condition characterized by persistent difficulties in social communication and interaction, restricted repetitive patterns in behaviour, interests and activities, and hyper or hyporeactivity to sensory stimuli. [
      • Tian J.
      • Gao X.
      • Yang L.
      Repetitive restricted behaviors in autism spectrum disorder: from mechanism to development of therapeutics.
      ] The symptoms are present early on in development and affect daily functioning. However, they may not become fully manifest until social demands exceed limited capacities or may be masked by learnt strategies later in life.
      The prevalence of ASD with mild or no intellectual disability in the UK is estimated at 1%. It has a male to female ratio of 2–3:1 in non-referred samples but this increases to 4:1 in clinical samples suggesting an ascertainment bias in the latter groups [
      • Lai M.C.
      • Baron-Cohen S.
      Identifying the lost generation of adults with autism spectrum conditions.
      ]. Common psychiatric co-morbidities include ADHD (attention-deficit/hyperactivity disorder), anxiety, depression, eating disorders, self-harm and obsessive compulsive traits [
      • Lai M.C.
      • Baron-Cohen S.
      Identifying the lost generation of adults with autism spectrum conditions.
      ]. The National Institute for Clinical Guidelines (NICE) recommended screening tool is the 10 item Autism Spectrum Quotient (AQ-10), with diagnostic assessment recommended for scores of 6 or above [

      Autism spectrum quotient (AQ-10) test | Autism spectrum disorder in adults: diagnosis and management | Guidance | NICE n.d. https://www.nice.org.uk/guidance/cg142/resources/autism-spectrum-quotient-aq10-test-143968 (accessed January 6, 2022).

      ].

      1.3 Alexithymia

      Alexithymia is a dimensional personality trait characterized by difficulties in identifying and describing one's own emotional state [
      • Williams Z.J.
      • Gotham K.O.
      Improving the measurement of alexithymia in autistic adults: a psychometric investigation of the 20-item Toronto alexithymia scale and generation of a general alexithymia factor score using item response theory.
      ]. As well as difficulty identifying feelings, it entails externally oriented thinking and a limited imaginal capacity. Rates in the general and autistic populations are estimated at 10 and 50% respectively [
      • Williams Z.J.
      • Gotham K.O.
      Improving the measurement of alexithymia in autistic adults: a psychometric investigation of the 20-item Toronto alexithymia scale and generation of a general alexithymia factor score using item response theory.
      ,
      • Franz M.
      • Popp K.
      • Schaefer R.
      • Sitte W.
      • Schneider C.
      • Hardt J.
      • et al.
      Alexithymia in the German general population.
      ]. Alexithymia is also prevalent in FND, with rates reported between 35%–75% [
      • Gulpek D.
      • Kelemence Kaplan F.
      • Kesebir S.
      • Bora O.
      Alexithymia in Patients with Conversion Disorder.
      ]. Alexithymic individuals may show significantly higher levels of “functional” somatic and psychiatric symptoms such as anxiety and depression compared to those without alexithymia [
      • Carano A.
      • de Berardis D.
      • Gambi F.
      • di Paolo C.
      • Campanella D.
      • Pelusi L.
      • et al.
      Alexithymia and body image in adult outpatients with binge eating disorder.
      ].

      1.4 ASD and FND

      The relationship between ASD and FND is relatively unexplored (see Box 1) [
      • Hatta K.
      • Hosozawa M.
      • Tanaka K.
      • Shimizu T.
      Exploring traits of autism and their impact on functional disability in children with somatic symptom disorder.
      ,
      • Nimmo-Smith V.
      • Heuvelman H.
      • Dalman C.
      • Lundberg M.
      • Idring S.
      • Carpenter P.
      • et al.
      Anxiety disorders in adults with autism spectrum disorder: a population-based study.
      ,
      • Jester K.A.
      • Londino D.L.
      • Hayman J.
      2.68 Examining the occurrence of conversion disorder diagnoses and asd among adolescents and young adults in the emergency departmenT.
      ,
      • McWilliams A.
      • Reilly C.
      • Gupta J.
      • Hadji-Michael M.
      • Srinivasan R.
      • Heyman I.
      Autism spectrum disorder in children and young people with non-epileptic seizures.
      ,
      • Nisticò V.
      • Goeta D.
      • Iacono A.
      • Tedesco R.
      • Giordano B.
      • Faggioli R.
      • et al.
      Clinical overlap between functional neurological disorders and autism spectrum disorders: a preliminary study.
      ,
      • Freedman D.A.
      • Terry D.
      • Enciso L.
      • Trott K.
      • Burch M.
      • Albert D.V.F.
      Brief report: psychogenic nonepileptic events in pediatric patients with autism or intellectual disability.
      ,
      • Freedman D.
      • Terry D.
      • Enciso L.
      • Trott K.
      • Burch M.
      • Albert D.
      Psychogenic nonepileptic events in pediatric patients with autism.
      ,
      • Rødgaard E.M.
      • Jensen K.
      • Miskowiak K.W.
      • Mottron L.
      Childhood diagnoses in individuals identified as autistics in adulthood.
      ,
      • Pun P.
      • Frater J.
      • Broughton M.
      • Dob R.
      • Lehn A.
      Psychological profiles and clinical clusters of patients diagnosed with functional neurological disorder.
      ,
      • Zdankiewicz-Scigała E.
      • Scigała D.
      • Sikora J.
      • Kwaterniak W.
      • Longobardi C.
      Relationship between interoceptive sensibility and somatoform disorders in adults with autism spectrum traits. The mediating role of alexithymia and emotional dysregulation.
      ,
      • Miersch H.C.
      A retrospective study of 131 patients with psychogenic non-epileptic seizures (PNES): comorbid diagnoses and outcome after inpatient treatment.
      ], One study looking at odds ratios (OR) of childhood diagnoses in autistic adults, reported an OR of 5.9 for dissociative and conversion disorders compared to adults without autism. [
      • Rødgaard E.M.
      • Jensen K.
      • Miskowiak K.W.
      • Mottron L.
      Childhood diagnoses in individuals identified as autistics in adulthood.
      ] Another population analysis reported an adjusted relative risk of 3.42 for somatoform disorder, and 6.45 for dissociative disorder. [
      • Nimmo-Smith V.
      • Heuvelman H.
      • Dalman C.
      • Lundberg M.
      • Idring S.
      • Carpenter P.
      • et al.
      Anxiety disorders in adults with autism spectrum disorder: a population-based study.
      ]
      Prior evidence from the literature on autistic traits and FND
      Very little work exploring the prevalence of autistic traits in patients with FND has been done. The existing literature is heterogeneous in terms of country, terminology, sample demographics, aims, methodology (whether autistic traits were assessed in people with FND, or whether functional symptoms were assessed in autistic people) and findings. Research has focused largely on the child and adolescent populations and/or on psychogenic non-epileptic seizures (PNES rather than wider functional symptoms (See Supplementary Material Fig. 1 and Table 1 for search strategy and results)).
      Two studies found no significant difference in autistic traits between adults with FND and controls [
      • Nisticò V.
      • Goeta D.
      • Iacono A.
      • Tedesco R.
      • Giordano B.
      • Faggioli R.
      • et al.
      Clinical overlap between functional neurological disorders and autism spectrum disorders: a preliminary study.
      ], with another finding the same in samples of children [
      • Hatta K.
      • Hosozawa M.
      • Tanaka K.
      • Shimizu T.
      Exploring traits of autism and their impact on functional disability in children with somatic symptom disorder.
      ]. Retrospective analyses assessing rates of comorbid diagnoses of ASD in patients with FND have reported higher rates compared to the general population [
      • Jester K.A.
      • Londino D.L.
      • Hayman J.
      2.68 Examining the occurrence of conversion disorder diagnoses and asd among adolescents and young adults in the emergency departmenT.
      ,
      • McWilliams A.
      • Reilly C.
      • Gupta J.
      • Hadji-Michael M.
      • Srinivasan R.
      • Heyman I.
      Autism spectrum disorder in children and young people with non-epileptic seizures.
      ,
      • Freedman D.
      • Terry D.
      • Enciso L.
      • Trott K.
      • Burch M.
      • Albert D.
      Psychogenic nonepileptic events in pediatric patients with autism.
      ,
      • Pun P.
      • Frater J.
      • Broughton M.
      • Dob R.
      • Lehn A.
      Psychological profiles and clinical clusters of patients diagnosed with functional neurological disorder.
      ,
      • Miersch H.C.
      A retrospective study of 131 patients with psychogenic non-epileptic seizures (PNES): comorbid diagnoses and outcome after inpatient treatment.
      ]. One study assessing comorbidity in autistic individuals found higher rates of FND compared to controls [
      • Nimmo-Smith V.
      • Heuvelman H.
      • Dalman C.
      • Lundberg M.
      • Idring S.
      • Carpenter P.
      • et al.
      Anxiety disorders in adults with autism spectrum disorder: a population-based study.
      ]. Higher rates of somatoform dissociation and alexithymia in an autistic sample compared to controls has been reported by one study [
      • Zdankiewicz-Scigała E.
      • Scigała D.
      • Sikora J.
      • Kwaterniak W.
      • Longobardi C.
      Relationship between interoceptive sensibility and somatoform disorders in adults with autism spectrum traits. The mediating role of alexithymia and emotional dysregulation.
      ]. Finally another study looking at odds ratios (OR) of childhood diagnoses in autistic adults, reported an OR of 5.9 for dissociative and conversion disorders compared to adults without autism [
      • Rødgaard E.M.
      • Jensen K.
      • Miskowiak K.W.
      • Mottron L.
      Childhood diagnoses in individuals identified as autistics in adulthood.
      ]. Full details of the systematic review can be found in the supplementary material.
      Certain features of autism, or associated traits, might act as perpetuating or precipitating factors. This includes differences in sensory processing (e.g., pain), cognition (attention, alexithymia) higher than average rates of psychiatric co-morbidity and risk of adverse life events, including bullying, abuse and exploitation. [
      • Taurines R.
      • Segura M.
      • Schecklmann M.
      • Albantakis L.
      • Grünblatt E.
      • Walitza S.
      • et al.
      Altered peripheral BDNF mRNA expression and BDNF protein concentrations in blood of children and adolescents with autism spectrum disorder.
      ,
      • Hannant P.
      • Cassidy S.
      • Tavassoli T.
      • Mann F.
      Sensorimotor difficulties are associated with the severity of autism spectrum conditions.
      ,
      • Griffiths S.
      • Allison C.
      • Kenny R.
      • Holt R.
      • Smith P.
      • Baron-Cohen S.
      The vulnerability experiences quotient (VEQ): a study of vulnerability, mental health and life satisfaction in autistic adults.
      ]
      Sensory processing patterns such as low neurological threshold, or sensory over responsivity (extreme sensitivity to or avoidance of sensory stimuli (e.g., loud sounds)) have both been reported in FND and ASD [
      • Nisticò V.
      • Goeta D.
      • Iacono A.
      • Tedesco R.
      • Giordano B.
      • Faggioli R.
      • et al.
      Clinical overlap between functional neurological disorders and autism spectrum disorders: a preliminary study.
      ,
      • Wood E.T.
      • Cummings K.K.
      • Jung J.
      • Patterson G.
      • Okada N.
      • Guo J.
      • et al.
      Sensory over-responsivity is related to GABAergic inhibition in thalamocortical circuits.
      ,
      • Ranford J.
      • MacLean J.
      • Alluri P.R.
      • Comeau O.
      • Godena E.
      • Curt LaFrance W.
      • et al.
      Sensory processing difficulties in functional neurological disorder: a possible predisposing vulnerability?.
      ]. Relevant to this are the known interoceptive differences associated with both ASD and FND. Interoception is the process by which the nervous system senses, interprets and integrates signals originating from within the body at conscious and unconscious levels [
      • Khalsa S.S.
      • Adolphs R.
      • Cameron O.G.
      • Critchley H.D.
      • Davenport P.W.
      • Feinstein J.S.
      • et al.
      Interoception and mental health: a roadmap.
      ].
      Nisticò et al. explored this and suggested that difficulties translating interoceptive signals into higher-order brain representations might result in poor integration of physiological responses to emotional cues. Adding to this the role of alexithymia, the failure to interpret autonomic arousal as anxiety occurring during a physical precipitating event might result in the interpretation of these sensations as symptoms of physical illness [
      • Nisticò V.
      • Goeta D.
      • Iacono A.
      • Tedesco R.
      • Giordano B.
      • Faggioli R.
      • et al.
      Clinical overlap between functional neurological disorders and autism spectrum disorders: a preliminary study.
      ,
      • Demartini B.
      • Petrochilos P.
      • Ricciardi L.
      • Price G.
      • Edwards M.J.
      • Joyce E.
      The role of alexithymia in the development of functional motor symptoms (conversion disorder).
      ]. In their paper on emotional processing in FND, Pick et al. highlight a transdiagnostic role of interoception, suggesting reduced integration between conscious emotional experience and somatic responses [
      • Pick S.
      • Goldstein L.H.
      • Perez D.L.
      • Nicholson T.R.
      Emotional processing in functional neurological disorder: a review, biopsychosocial model and research agenda.
      ]. Relevant to this is the possible therapeutic role of interoceptive training explored in samples of autistic and somatoform patients [
      • Pick S.
      • Goldstein L.H.
      • Perez D.L.
      • Nicholson T.R.
      Emotional processing in functional neurological disorder: a review, biopsychosocial model and research agenda.
      ,
      • Schaefer M.
      • Egloff B.
      • Gerlach A.L.
      • Witthöft M.
      Improving heartbeat perception in patients with medically unexplained symptoms reduces symptom distress.
      ,
      • Quadt L.
      • Garfinkel S.N.
      • Mulcahy J.S.
      • Larsson D.E.
      • Silva M.
      • Jones A.-M.
      • et al.
      Interoceptive training to target anxiety in autistic adults (ADIE): A single-center, superiority randomized controlled trial-NC-ND license.
      ].
      These factors highlight a need to further explore whether an association exists; this paper focuses on the prevalence of autistic traits and alexithymia in participants of a 5-week outpatient based (day-case) individualised treatment programme for FND in the UK [
      • Petrochilos P.
      • Elmalem M.S.
      • Patel D.
      • Louissaint H.
      • Hayward K.
      • Ranu J.
      • et al.
      Outcomes of a 5-week individualised MDT outpatient (day-patient) treatment programme for functional neurological symptom disorder (FNSD).
      ]. Autistic traits may act as underlying factors which could be considered in the treatment strategy.
      We aim to:
      • 1.
        Report the prevalence of autistic traits in an outpatient group of adults diagnosed with FND.
      • 2.
        Report the prevalence of alexithymia
      • 3.
        Report differences in symptom severity of psychiatric comorbidity between those scoring below 6 versus 6 and above on the AQ-10, and by alexithymia status
      • 4.
        Explore the association between autistic traits and psychiatric comorbidities as mediated by alexithymia scores

      2. Methods

      2.1 Ethical approval

      The study was approved as a service evaluation by the departmental audit lead, registered with the quality and safety forum of UCLH NHS Foundation trust, thus not requiring ethics committee approval.

      2.2 Sample/participants

      This study was set in the Neuropsychiatry department of a tertiary neurological hospital. All patients had been diagnosed with FND by a neurologist and presented with functional movement, sensory and non-epileptic seizures and combinations of these. Further details of the referral pathway are found in Petrochilos et al. 2020 paper. [
      • Petrochilos P.
      • Elmalem M.S.
      • Patel D.
      • Louissaint H.
      • Hayward K.
      • Ranu J.
      • et al.
      Outcomes of a 5-week individualised MDT outpatient (day-patient) treatment programme for functional neurological symptom disorder (FNSD).
      ] See Table 3 in supplementary material for DSM-V diagnostic criteria for FND. [
      • Stone J.
      Functional neurological disorders: the neurological assessment as treatment.
      ,
      • American Psychiatric Association
      Diagnostic and Statistical Manual of Mental Disorders.
      ]
      Data was collected between December 2019 and December 2021 when 105 patients participated in a 5-week individualised MDT outpatient (day-case) treatment programme for FND in the department of Neuropsychiatry at NHNN in the UK. Complete data sets were obtained from 91 (87%) patients for self-report measures of autistic traits, alexithymia, generalised anxiety, depression, somatic symptom severity, social phobia, panic phobia, work and social adjustment scale, dyslexia, and ADHD. Service referral letters for the 91 patients were reviewed retrospectively for the predominant functional symptom.

      2.3 Self-report measures

      Measures (described in Supplementary Material Table 2) were collected at the start of the program. These included the AQ-10, Toronto Alexithymia Scale (TASS-20), Patient Health Questionnaire (PHQ9), Generalised Anxiety Disorder-7 (GAD-7), Social Phobia Inventory, Work and Social Adjustment Scale (WSAS), Somatic Symptom Questionnaire (PHQ-15), Adult ADHD Self-Report Scale (ASRS v.1.1), The Adult Dyslexia Checklist, and the IAPT phobia scale. The cuttoffs for the TASS-20 were: 50 = no alexithymia, 51–60 = borderline alexithymia, and ≥ 61 = alexithymia.

      2.4 Statistical analysis

      Patients were grouped between those scoring <6 or ≥ 6 on the AQ-10 and compared for significant differences on the other measures. Data were tabulated and analysed descriptively using SPSS version 25. For each of the measures, a Mann-Whitney U test was performed to explore differences between the patient groups scoring <6 or ≥ 6 on the AQ-10.
      Patients were then grouped by alexithymia status (no alexithymia, possible alexithymia, and alexithymia) and a Kruskal-Wallis H was performed to explore differences in self-report measured between alexithymia status groups, using standard clinical cut-offs. Simple effects were explored by performing pairwise comparisons.
      We further sought to explore the association between autistic traits and psychiatric co-morbidities as mediated by alexithymia scores.
      The proposed mediation models were tested in a single, bootstrapping-based model with 5000 iterations to assess the significance of the indirect effects between the independent (X: AQ-10) and the dependent (Y: psychiatric comorbidities) variable at the levels of the mediator variable (M: TAS-20). Age and sex were entered as covariates [

      Introduction to Mediation, Moderation, and Conditional Process Analysis: A Regression-Based Approach. - PsycNET n.d. https://psycnet.apa.org/record/2013-21121-000 (accessed January 5, 2023).

      ] (see Fig. 1). Table 4 provides the statistical results obtained from each of the models performed.
      Fig. 1
      Fig. 1Flow chart of mediation analysis model. The figure shows the multistep regression algorithm applied in the mediation analysis model, to test the direct and indirect relationships between the predictor (X), the outcome (Y) and the mediator (M) variables.

      3. Results

      Data was analysed for 91 patients, 69 (75.8%) were female and 22 (24.2%) were male. 39.6% scored AQ-10 positive and 60.4% scored AQ-10 negative. Of the AQ-10 positive group, 61.1% were females and 38.9% of males (Table 1). The probability of scoring AQ-10 positive was 31.9% for females and 63.63% for males (Table 2). Of the AQ-10 negative group (60.4% of the total), 85.5% were female and 14.5% were male. The probability of scoring AQ-10 negative was 68% for females and 36% for males. (See Table 1b.)
      Table 1Demographic and Clinical Characteristics.
      Total

      (N = 91)
      AQ-10 Positive

      (n = 36)
      AQ-10 Negative

      (n = 55)
      Age (SD)43.42 (13.39)41.5 (12.92)46.4 (13.61)
      Female (%)69 (75.8)22 (61.1)47 (85.5)
      Male (%)22 (24.2)14 (38.9)8 (14.5)
      In receipt of illness-related benefits (%)47 (51.6)20 (55.6)27 (49.1)
      Employment status (%)
       Full time employed22 (24.2)7 (19.4)15 (27.3)
       Part time employed15 (16.5)4 (11.1)11 (20)
       Unemployed34 (37.3)18 (50)16 (29.1)
       Full time student1 (1.1)1 (2.8)0 (0)
       Retired14 (15.4)4 (11.1)10 (18.2)
       Homemaker/carer3 (3.3)1 (2.8)2 (3.6)
       Unknown2 (2.2)1 (2.8)1 (1.8)
      Education (%) (highest level obtained)
       Primary (%)0 (0)0 (0)0 (0)
       Secondary lower4 (4.4)0 (0)4 (7.3)
       GCSE, O level, CSE19 (20.9)14 (38.9)5 (9.1)
       Further education1 (1.1)0 (0)1 (1.8)
       HND/NVQ/BTEC12 (13.1)7 (19.4)5 (9.1)
       Secondary higher (A levels)10 (11)1 (2.8)9 (16.4)
       University degree30 (33)8 (22.2)22 (40)
       University masters7 (7.7)2 (5.6)5 (9.1)
       University doctorate2 (2.2)1 (2.8)1 (1.8)
       Unknown6 (6.6)3 (5.5)3 (5.5)
      Predominant symptom (%)
       Functional motor45 (49.4)17 (47.2)28 (50.9)
       Non-epileptic episodes19 (20.9)6 (16.7)13 (23.6)
       Other (PPPD, cognition, sensory)27 (29.7)13 (36.1)14 (25.5)
      TAS: Alexithymia (%)
       Alexithymia positive36 (40.0)21 (58.3)17 (30.9)
       Probable alexithymia15 (16.4)6 (16.7)9 (16.4)
       No alexithymia37 (40.7)9 (25.0)28 (50.9)
       Unknown2 (2.2)1 (2.7)1 (1.8)
      GAD7: Anxiety (%)
       Severe anxiety (>15)28 (30.8)15 (41.7)13 (23.6)
       Moderate anxiety (10–14)18 (19.7)7 (19.4)11 (20)
       No anxiety (<10)45 (49.5)14 (38.9)31 (56.4)
      PHQ9: Depression (%)
       Severe depression (20–27)18 (19.8)10 (27.8)8 (14.5)
       Mod-severe depression (15–19)23 (25.2)13 (36.1)10 (18.2)
       Moderate depression (10–14)16 (17.6)6 (16.7)10 (18.2)
       No depression (<10)34 (37.4)7 (19.4)27 (49.1)
      SPIN: Social phobia (%)
       Very severe social phobia (>51)7 (7.7)3 (8.3)4 (7.3)
       Severe social phobia (41–50)7 (7.7)4 (11.1)3 (5.5)
       Moderate social phobia (31–40)16 (17.6)10 (27.8)6 (10.9)
        or no social phobia (〈31)61 (67)19 (52.8)42 (76.3)
      Adult Dyslexia Checklist: Dyslexia (%)
       Moderate-severe dyslexia (>60)7 (7.7)4 (11.1)3 (5.5)
       Mild dyslexia (45–60)35 (38.5)18 (50)17 (30.9)
       No dyslexia (<45)49 (53.8)14 (38.9)35 (63.6)
      ASRS: ADHD (%)
       Warrant assessment for ADHD (>4)16 (17.6)8 (22.2)8 (14.5)
       No ADHD (<4)75 (82.4)28 (77.8)47 (85.5)
      Table 2Group Comparison between AQ-10 Positive and AQ-10 Negative in Psychiatric Comorbidities
      As data were not normally distributed, the descriptive values are the median and mean ranks.
      .
      DescriptiveStatistics
      AQ-10
      Autism Spectrum Quotient. A total score of ≥6 is positive.
      Positive

      (n = 36)
      AQ-10 Negative

      (n = 55)
      Mann Whitney Test
      MeasureMedianMean RankMedianMean RankStandardised U Statistic
      for the test statistics value the mean ranks were used.
      p value
      ASRS
      Adult Self-Report ADHD Scale (v1.1).
      256.28139.273.070.002
      TAS-20
      Total Alexithymia Score.
      (Total)
      63.558.695137.693.71<0.001
       Describing feelings1755.581439.732.800.005
       Identifying feelings2454.441940.472.470.013
       Externally oriented thinking21.556.681839.013.120.002
      PHQ9
      Patient Health Questionnaire-9.
      1756.261039.283.000.003
      PHQ15
      Patient Health Questionnaire-15.
      13.551.331242.511.56n.s
      non-significant.
      GAD7
      Generalised Anxiety Disorder Assessment.
      1253.88840.852.300.021
      SPIN
      Social Phobia Inventory.
      2753.811940.892.280.023
      IAPT Phobia Scale
      Improving Access to Psychological Therapies Phobia Scale.
      (Total)
      11.553.11641.352.080.037
       Social Phobia351.99242.081.7n.s
       Panic Phobia3.552.57241.701.95n.s
       Object and Action Phobia351.01142.721.51n.s
      WSAS
      Work and Social Adjustment Scale.
      2254.431740.482.460.014
      Adult Dyslexia Checklist4857.533838.453.370.001
      Compared to AQ-10 negative, AQ-10 positive patients had higher median ranks of ASRS (56.28 vs. 39.27, U = 3.07, p = 0.002), TAS-20 (58.69 vs. 37.69, U = 3.71, p < 0.001), PHQ-9 (56.26 vs. 39.28, U = 3, p = 0.003), GAD-7 (53.88 vs. 40.85, U = 2.30, p = 0.003), SPIN-7 (53.81 vs. 40.89, U = 2.28, p = 0.023), IAPT Phobia Scale (53.11 vs. 41.35, U = 2.08, p = 0.037), WSAS (54.43 vs. 40.48, U = 2.46, p = 0.014), and the Adult Dyslexia Checklist (57.53 vs. 38.45, U = 3.37, p = 0.001. No differences were obtained for PHQ15, and social, panic and object and action phobias IAPT subscales.
      1 As data were not normally distributed, the descriptive values are the median and mean ranks.
      2 Autism Spectrum Quotient. A total score of ≥6 is positive.
      3 for the test statistics value the mean ranks were used.
      4 non-significant.
      a Adult Self-Report ADHD Scale (v1.1).
      b Total Alexithymia Score.
      c Patient Health Questionnaire-9.
      d Patient Health Questionnaire-15.
      e Generalised Anxiety Disorder Assessment.
      f Social Phobia Inventory.
      g Improving Access to Psychological Therapies Phobia Scale.
      h Work and Social Adjustment Scale.
      Table 1bProbability of scoring positive or negative on the AQ-10 by gender.
      AQ Positive n = 36AQ Negative n = 55
      Females n = 6931.8%68%
      Males n = 2263%36%
      For the whole group, 37% were unemployed, 24% were full-time employed and 16.5% were part-time employed. Compared to the AQ-10 negative group, the AQ-10 positive group, rates for unemployment were higher (50%) and rates of full-time employment (19.4%) and part-time employment (11.1%) were lower.
      Regarding highest education attainment level, the AQ-10 positive group had highest rates for GCSEs (38.9%), followed by HND/NVQ/BTEC (19.4%) and university degree (22%). The AQ negative group was highest for university degree (40%) A levels (16.4%) and then GCSEs (9.1%), HND (9.1%) and University master's degree (9.1%). Regarding predominant symptoms, the AQ-10 positive group compared to the AQ-10 negative group had similar rates of functional motor symptoms (47.2% and 50.9% respectively). However, they had slightly lower rates of non-epileptic episodes (16.7% versus 23.6%) and higher rates of other functional symptoms (e.g., PPPD, cognition and sensory) (36.1% versus 25.5%) compared to the AQ-10 negative group.

      3.1 AQ-10 group differences

      Differences in psychiatric comorbidity scores were explored between patients with a positive vs. negative AQ-10 status. A Mann-Whitney test was performed for each of the contrasts. Table 2 summarises the descriptive and statistical results.

      3.2 TAS-20 group differences

      Differences in psychiatric comorbidity scores were explored between patients with a (1) negative (2) possible or (3) positive TAS-20 status by performing Kruskal Wallis tests. . Table 3 summarises the statistical results.
      Table 3Group Comparison between Alexithymia Status Groups in Psychiatric Comorbidities
      As data were not normally distributed, the descriptive values are the mean ranks.
      Autism Spectrum Quotient. A total score of ≥6 is positive [5].
      ,
      Total Alexithymia Score [6].
      .
      DescriptiveStatistics
      (I)

      No Alexithymia (n = 33)
      (II)

      Possible Alexithymia (n = 22)
      (III)

      Alexithymia (n = 36)
      Independent Samples Kruskal Wallis TestPost-hoc analysis
      MeasureMedianMean RankMedianMean RankMedianMean Rankχ2 Test Statistic
      For the test statistics value the mean ranks were used.
      p valuePairwise Comparisons
      ASRS
      Adult Self-Report ADHD Scale (v1.1).
      139.35247.25250.293.210.2Not applicable
      AQ-10435.03547.98653.819.250.01I = II; I < III⁎⁎; II = III
      PHQ9
      Patient Health Questionnaire-9.
      937.791239.181756.7410.670.005⁎⁎I = II; I < III⁎⁎; II < III
      PHQ15
      Patient Health Questionnaire-15.
      1141.0211.536.911555.138.130.017I = II; I < III; II = III
      GAD7
      Generalised Anxiety Disorder - 7.
      634.619.544.051556.6912.250.002⁎⁎I = II; I < III⁎⁎; II = III
      SPIN
      Social Phobia Inventory.
      1433.031942.003059.4617.91<0.000⁎⁎⁎I = II; I < III⁎⁎⁎; II < III
      IAPT Phobia Scale
      Improving Access to Psychological Therapies Phobia Scale.
      (Total)
      433.056.542.661259.0317.25<0.000⁎⁎⁎I = II; I < III⁎⁎⁎; II = III
      Social Phobia235.17243.30656.6312.040.002⁎⁎I = II; I < III⁎⁎; II = III
      Panic Phobia131.292.544.43459.5720.59<0.000⁎⁎⁎I = II; I < III⁎⁎⁎; II = III
      Object and Action Phobia138.95141.36354.276.990.03I = II; I < III; II = III
      WSAS
      Work and Social Adjustment Scale.
      1742.682048.392146.340.690.708Not applicable
      Adult Dyslexia Checklist3936.8341.546.804652.866.460.039*I = II; I < III; II = III
      p < 0.05 ⁎⁎ p < 0.01 ⁎⁎⁎ p < 0.001.
      1 As data were not normally distributed, the descriptive values are the mean ranks.
      2 Autism Spectrum Quotient. A total score of ≥6 is positive [

      Autism spectrum quotient (AQ-10) test | Autism spectrum disorder in adults: diagnosis and management | Guidance | NICE n.d. https://www.nice.org.uk/guidance/cg142/resources/autism-spectrum-quotient-aq10-test-143968 (accessed January 6, 2022).

      ].
      3 For the test statistics value the mean ranks were used.
      a Adult Self-Report ADHD Scale (v1.1).
      b Total Alexithymia Score [
      • Williams Z.J.
      • Gotham K.O.
      Improving the measurement of alexithymia in autistic adults: a psychometric investigation of the 20-item Toronto alexithymia scale and generation of a general alexithymia factor score using item response theory.
      ].
      c Patient Health Questionnaire-9.
      d Patient Health Questionnaire-15.
      e Generalised Anxiety Disorder - 7.
      f Social Phobia Inventory.
      g Improving Access to Psychological Therapies Phobia Scale.
      h Work and Social Adjustment Scale.

      3.2.1 AQ-10

      The model returned a significant effect for differences in AQ-10 median ranks scores as a function of TAS status (χ2 = 3.21, p = 0.01). Simple effects analysis revealed that TAS-20 negative had a lower mean rank compared with TAS-20-positive patients (35.03 vs 53.81, p < 0.01).

      3.2.2 PHQ9

      The model returned a significant effect for differences in PHQ9 median ranks scores as a function of TAS status (χ2 = 10.67, p = 0.005). Simple effects analysis revealed that TAS-20 negative had a lower mean rank compared with TAS-20-positive patients (37.79 vs. 56.74, p < 0.01). Further, patients with possible alexithymia had lower PHQ9 scores compared with those with a positive status (39.18 vs 56.74, p < 0.05).

      3.2.3 PHQ15

      The model returned a significant effect for differences in PHQ15 median ranks scores as a function of TAS status (χ2 = 8.13, p = 0.017). Simple effects analysis revealed that TAS-20 negative had a lower mean rank compared with TAS-20-positive patients (41.02 vs. 55.13, p < 0.05).

      3.2.4 GAD7

      The model returned a significant effect for differences in GAD7 median ranks scores as a function of TAS status (χ2 = 12.25, p = 0.002). Simple effects analysis revealed that TAS-20 negative had a lower mean rank compared with TAS-20-positive patients (34.61 vs. 56.69, p < 0.01).

      3.2.5 SPIN

      The model returned a significant effect for differences in SPIN median ranks scores as a function of TAS status (χ2 = 17.91, p < 0.001). Simple effects analysis revealed that TAS-20 negative had a lower mean rank compared with TAS-20-positive patients (33.03 vs. 59.46, p < 0.001). Further, patients with possible alexithymia had lower SPIN scores compared with those with a positive status (42 vs. 59.46, p < 0.05).

      3.2.6 IAPT phobia scale

      The model returned a significant effect for differences in phobia median ranks scores as a function of TAS status (χ2 = 17.25, p < 0.001). Simple effects analysis revealed that TAS-20 negative had a lower mean rank compared with TAS-20-positive patients (33.05 vs. 59.03, p < 0.001). Similar trends were obtained for the social, object and action and panic sub-scales (Table 3).

      3.2.7 Adult dyslexia checklist

      The model returned a significant effect for differences in dyslexia median ranks scores as a function of TAS status (χ2 = 6.46, p = 0.039). Simple effects analysis revealed that TAS-20 negative had a lower mean rank compared with TAS-20-positive patients (36.83 vs. 52.86, p < 0.05).
      Table 4|Statistical results of the direct (c′) and indirect (m) regression models applied to determine if a mediation relationship exists between the predictor variable (X: AQ-10), the psychiatric comorbidities outcome variables (Y) and the mediator variable (M: TAS scores).
      Table 4Statistical results of direct and indirect effects of AQ-10 scores on psychiatric comorbidities mediated by TAS scores.
      Outcome (Y)Predictor (X)

      AQ-10 Total
      Mediator (M)

      TAS Total
      Direct Coefficient

      X ∼ Y (c′)
      tp value95% CIEffect size (%)Indirect Coefficient

      X ∼ Y (m)
      95% CIEffect size

      (%)
      PHQ90.77492.150.0339[0.06, 1.48]69.40.3425[0.04, 0.79]30.6
      PHQ150.70862.380.0194[0.04, 0.79]83.30.14220.07, 0.44]16.7
      GAD70.66891.920.05790.02, 1.36]68.10.3140[0.01, 0.76]31.9
      SPIN0.69560.910.36100.81, 2.20]37.81.1479[0.38, 2.34]62.2
      IAPT Phobia Scale0.49101.360.17560.22, 1.20]49.80.4950[0.18, 0.96]50.2
      WSAS0.86511.780.0785[−0.1, 1.8379.20.2276[−0.09, 0.61]20.8
      Adult Dyslexia Checklist1.56892.540.0127[0.34, 2.79]77.00.4696[−0.001, 1.15]23.0

      3.2.8 PHQ9

      Overall model returned a significant, positive direct association between AQ-10 and PHQ9 scores (c′ = 0.7749, t = 2.15, p = 0.0339, 95% CI = [0.06, 1.48]) so that higher AQ-10 scores were associated with higher PHQ9 scores, accounting for 69.4% of the variability in PHQ9 scores. The mediation model was supported (m = 0.3425, 95% CI = [0.04, 0.79]) with a moderate effect size of 30.6% (Fig. 1a).

      3.2.9 PHQ15

      Overall model returned a significant, positive direct association between AQ-10 and PHQ15 scores (c′ = 0.7086, t = 2.38, p = 0.0194, 95% CI = [0.06, 1.48]) so that higher AQ-10 scores were associated with higher PHQ15 scores, accounting for 83.3% of the variability in PHQ9 scores. The mediation model was not supported (m = 0.1422, 95% CI = [0.04, 0.79]) (Fig. 1b).

      3.2.10 GAD7

      Overall model returned a non-significant direct association between AQ-10 and GAD7 scores (c′ = 0.6956, t = 0.92, p = 0.361, 95% CI = [−0.02, 1.36]) so that higher AQ-10 scores were not associated with higher GAD7 scores. Given the absence of significant relationship between the predictor and the outcome variable, mediation effect is not applicable (Fig. 1 and Fig. 2c ).
      Fig. 2
      Fig. 2Coefficients obtained from the multi-step regression analyses employed to establish the presence of a mediation effect (M) between the predictor variable (X: AQ-10), outcome variable (Y: psychiatric comorbidities) by TAS scores (M). pairwise effects are shown (a1 [X ∼ M], a2 [M ∼ Y], c′ [direct effect X ∼ Y], and m [indirect effect X ∼ Y]). Statistically significant effects are labelled with *. TAS score was found to mediate the relationship between AQ-10, PHQ-9, PHQ-15 and dyslexia scores.

      3.2.11 SPIN

      Overall model returned a non-significant direct association between AQ-10 and SPIN scores (c′ = 0.7086, t = 2.38, p = 0.0579, 95% CI = [−0.81, 2.20]) so that higher AQ-10 scores were not associated with higher SPIN scores (Fig. 1 and Fig. 2d).

      3.2.12 Phobia

      Overall model returned a non-significant direct association between AQ-10 and phobia total scores (c′ = 0.4910, t = 1.36, p = 0.1756, 95% CI = [−0.22, 1.20]) so that higher AQ-10 scores were not associated with higher phobia scores (see Fig. 1 and Fig. 2e).

      3.2.13 WSAS

      Overall model returned a non-significant direct association between AQ-10 and WSAS scores (c′ = 0.8651, t = 1.78, p = 0.0785, 95% CI = [−0.1, 1.83]) so that higher AQ-10 scores were not associated with higher WSAS scores (Fig. 1 and Fig. 2f).

      3.2.14 Dyslexia

      Overall model returned a significant, positive direct association between AQ-10 and dyslexia scores (c′ = 1.5689, t = 2.54, p = 0.0127, 95% CI = [0.34, 2.79]) so that higher AQ-10 scores were associated with higher dyslexia scores, accounting for 77% of the variability in dyslexia scores. The mediation model was not supported (m = 0. 4696, 95% CI = [−0.001, 1.15]), suggesting that there is no ground for a mediation effect of level of alexithymia scores on the direct relationship between autistic traits and dyslexia levels (see Fig. 1g).

      4. Discussion

      This study aimed to assess the prevalence of autistic traits and alexithymia in a group of adults with FND, as well as explore associated psychopathology and the mediating role of alexithymia.
      • We report new evidence of high rates of autistic traits, as measured by the AQ-10, in a group of adults with mixed FND symptoms. 40% of participants were AQ-10 positive, meeting the recommended threshold for consideration of a formal autism diagnostic assessment [
        • American Psychiatric Association
        Diagnostic and Statistical Manual of Mental Disorders.
        ]. [
        • Allison C.
        • Auyeung B.
        • Baron-Cohen S.
        Toward brief “red flags” for autism screening: the short autism spectrum quotient and the short quantitative checklist for autism in toddlers in 1,000 cases and 3,000 controls [corrected].
        ]
      • The probability of scoring AQ-10 positive was 31.8% for females and 63.6% for males.
      • We report further evidence of FND associated with high prevalence of alexithymia (40%) with a group mean TASS-20 score of 54.87.
      • Alexithymia mediates the association between AQ-10 and PHQ9 (depression) scores with a moderate effect size of 30.6%.

      4.1 Prevalence of ASD traits in FND

      Our findings differ from Nisticò et al.'s finding of no patients in an FND sample being AQ-50 positive [
      • Nisticò V.
      • Goeta D.
      • Iacono A.
      • Tedesco R.
      • Giordano B.
      • Faggioli R.
      • et al.
      Clinical overlap between functional neurological disorders and autism spectrum disorders: a preliminary study.
      ]. This may be due to a different study design; their use of the AQ-50 and a smaller sample of FND patients. They did however report that 86.7% of their sample with diagnosed ASD reported at least one functional neurological symptom, a prevalence significantly higher than the one encountered in their neurotypical sample (35.6%). They also found that tactile hypersensitivity was a risk factor for functional weakness and paraesthesia.
      The AQ positive group (i.e. scoring 6 or above) had a higher proportion of males, higher rates of unemployment, alexithymia, severe generalised anxiety and severe depression, more moderate-severe dyslexia and a higher proportion meeting threshold for a recommended ADHD assessment (see Table 2). Statistical analysis revealed that this group also scored significantly higher on self-report measures of alexithymia, depression, generalised anxiety, social phobia, total phobia, day-to-day functional impairment, ADHD, and dyslexia. These findings are consistent with known comorbidities in the ASD population [
      • Nisticò V.
      • Goeta D.
      • Iacono A.
      • Tedesco R.
      • Giordano B.
      • Faggioli R.
      • et al.
      Clinical overlap between functional neurological disorders and autism spectrum disorders: a preliminary study.
      ].

      4.2 Prevalence of alexithymia and its mediation effect on AQ-10 positive scores and depression

      We report further evidence of FND associated with a high prevalence of alexithymia (40%) with a group mean TASS-20 score of 54.87. This is higher than a reported prevalence of 34.5% (mean score of 55.38) in a previous NHNN outpatient group with functional motor symptoms (FMS) [
      • Demartini B.
      • Petrochilos P.
      • Ricciardi L.
      • Price G.
      • Edwards M.J.
      • Joyce E.
      The role of alexithymia in the development of functional motor symptoms (conversion disorder).
      ].
      The differing prevalence of alexithymia between our AQ-10 positive group (55.6%) and AQ-10 negative group (30.9%), may reflect that alexithymia is known to be common in ASD and reportedly up to 49.93% [
      • Williams Z.J.
      • Gotham K.O.
      Improving the measurement of alexithymia in autistic adults: a psychometric investigation of the 20-item Toronto alexithymia scale and generation of a general alexithymia factor score using item response theory.
      ]. However, our finding of a 30.9% prevalence in our AQ-10 negative group may reflect alexithymia's association with depression and FND [
      • Demartini B.
      • Petrochilos P.
      • Ricciardi L.
      • Price G.
      • Edwards M.J.
      • Joyce E.
      The role of alexithymia in the development of functional motor symptoms (conversion disorder).
      ]. By contrast, alexithymia prevalence in neurotypical individuals has been found to be much lower at 4.89% [
      • Kinnaird E.
      • Stewart C.
      • Tchanturia K.
      Investigating alexithymia in autism: a systematic review and meta-analysis.
      ], and 10% in the general population [
      • Williams Z.J.
      • Gotham K.O.
      Improving the measurement of alexithymia in autistic adults: a psychometric investigation of the 20-item Toronto alexithymia scale and generation of a general alexithymia factor score using item response theory.
      ].
      The alexithymic group scored significantly higher on self-report measures of autistic traits, depression, somatic symptom severity, generalised anxiety, social phobia, total phobia and dyslexia. When assessing for the presence of a mediation effect of TAS-20 (alexithymia) score in the association between autistic traits and scores of psychiatric comorbidities, it was found to be true for the depression (PHQ9) score with a moderate effect size (30%). This supports the previously reported strong associations between alexithymia and depression [
      • Hemming L.
      • Haddock G.
      • Shaw J.
      • Pratt D.
      Alexithymia and its associations with depression, suicidality, and aggression: an overview of the literature.
      ].
      The strong association between AQ-10 score and PHQ15 score (accounting for 83.3% of the variability) suggests that autistic traits are associated with high severity of somatic symptoms.

      4.3 Use of the AQ-10

      The AQ-10 was developed as a brief screen for ASD for use with adults with average or above average intellectual functioning and it is important to note that it is not a diagnostic tool. [
      • Allison C.
      • Auyeung B.
      • Baron-Cohen S.
      Toward brief “red flags” for autism screening: the short autism spectrum quotient and the short quantitative checklist for autism in toddlers in 1,000 cases and 3,000 controls [corrected].
      ] However those with elevated autistic traits can experience similar difficulties to diagnosed autistic people, such as sensory hypersensitivity and difficulties with social communication and sensorimotor skills [
      • Hannant P.
      • Cassidy S.
      • Tavassoli T.
      • Mann F.
      Sensorimotor difficulties are associated with the severity of autism spectrum conditions.
      ]. Previous research has also confirmed an increased prevalence of psychiatric diagnoses in both autistic people and those with elevated autistic traits [
      • Griffiths S.
      • Allison C.
      • Kenny R.
      • Holt R.
      • Smith P.
      • Baron-Cohen S.
      The vulnerability experiences quotient (VEQ): a study of vulnerability, mental health and life satisfaction in autistic adults.
      ,

      The Oxford Handbook of Autism and Co-Occurring Psychiatric Conditions - Google Books n.d. https://www.google.co.uk/books/edition/The_Oxford_Handbook_of_Autism_and_Co_Occ/g5TgDwAAQBAJ?hl=en&gbpv=1&pg=PP1&printsec=frontcover (accessed December 5, 2022).

      ,
      • Cassidy S.
      • Au-Yeung S.
      • Robertson A.
      • Cogger-Ward H.
      • Richards G.
      • Allison C.
      • et al.
      Autism and autistic traits in those who died by suicide in England.
      ].
      The AQ-10 is advantageous in that it is self-administered, brief and forced choice with, with Alliston et al. reporting a sensitivity of 0.88, specificity of 0.91, and positive predictive value (PPV) of 0.85 (with a cut off-of 6), whilst Booth et al. reported a sensitivity of 79.87 and specificity of 87.31 [
      • Allison C.
      • Auyeung B.
      • Baron-Cohen S.
      Toward brief “red flags” for autism screening: the short autism spectrum quotient and the short quantitative checklist for autism in toddlers in 1,000 cases and 3,000 controls [corrected].
      ,
      • Booth T.
      • Murray A.L.
      • McKenzie K.
      • Kuenssberg R.
      • O’Donnell M.
      • Burnett H.
      Brief report: an evaluation of the AQ-10 as a brief screening instrument for asd in adults.
      ]. More recently however, Ashwood et al. investigated the AQ questionnaire as a predictor of ASD caseness in a large sample of adults and reported a high sensitivity (0.77) but low specificity (0.29), with two-thirds of the patients who scored below the cut-off score of 6 being ‘false negatives’.
      The fact that we administered the AQ-10 on patients, i.e. not the general population, might increase the risk of false positive. Building on this, a further consideration is whether co-morbidities are inflating the AQ-10 scores. One group's co-morbidity data revealed that in their sample, GAD may ‘mimic’ ASD and inflate AQ scores, leading to false positives [
      • Ashwood K.L.
      • Gillan N.
      • Horder J.
      • Hayward H.
      • Woodhouse E.
      • McEwen F.S.
      • et al.
      Predicting the diagnosis of autism in adults using the autism-spectrum quotient (AQ) questionnaire.
      ]. However, in our study higher GAD-7 scores were not directly associated with higher AQ-10 scores (Table 4, Fig. 2) but PHQ9, PHQ15 and dyslexia were.
      There is a long history of sex bias in autism diagnosis, and it is important to consider this with screening measures. Females with ASD may, for example, fail to endorse some items because they refer to more typically male manifestations [
      • Murray A.L.
      • Allison C.
      • Smith P.L.
      • Baron-Cohen S.
      • Booth T.
      • Auyeung B.
      Investigating diagnostic bias in autism spectrum conditions: an item response theory analysis of sex bias in the AQ-10.
      ]. Murray et al. evaluated whether the AQ-10 exhibits such a bias, finding that although individual items showed some sex bias, these biases at times favoured males and at other times favoured females. Thus, at the level of test scores the item-level biases cancelled out to give an unbiased overall score. These findings were replicated in a later study [
      • Murray A.L.
      • Booth T.
      • Auyeung B.
      • McKenzie K.
      • Kuenssberg R.
      Investigating sex bias in the AQ-10: a replication study.
      ].

      4.4 Interpretation of findings

      Whilst we cannot infer causality, nor conclude on the role of diagnosed autism in FND, there are several points to consider from the literature when interpreting the finding of a high prevalence of autistic traits in our FND sample.
      Emotional and sensory processing are important factors to consider given their aetiological role in FND and clinical significance in ASD, and it is notable that Nisticò et al. reported tactile hypersensitivity as a risk factor for functional weakness [
      • Nisticò V.
      • Goeta D.
      • Iacono A.
      • Tedesco R.
      • Giordano B.
      • Faggioli R.
      • et al.
      Clinical overlap between functional neurological disorders and autism spectrum disorders: a preliminary study.
      ]. FND patients are more likely to report physiological markers of panic and anxiety, without reporting an emotional state of anxiety; ‘panic attack without panic’ [
      • Demartini B.
      • Petrochilos P.
      • Ricciardi L.
      • Price G.
      • Edwards M.J.
      • Joyce E.
      The role of alexithymia in the development of functional motor symptoms (conversion disorder).
      ,
      • Jungilligens J.
      • Paredes-Echeverri S.
      • Popkirov S.
      • Barrett L.F.
      • Perez D.L.
      A new science of emotion: implications for functional neurological disorder.
      ,
      • Goldstein L.H.
      • Mellers J.D.C.
      Ictal symptoms of anxiety, avoidance behaviour, and dissociation in patients with dissociative seizures.
      ]. This is supported by evidence of greater physiological arousal, higher baseline cortisol and greater threat vigilance in FND, alongside higher levels of alexithymia [
      • Sojka P.
      • Bareš M.
      • Kašpárek T.
      • Světlák M.
      Processing of emotion in functional neurological disorder.
      ,
      • Seignourel P.J.
      • Miller K.
      • Kellison I.
      • Rodriguez R.
      • Fernandez H.H.
      • Bauer R.M.
      • et al.
      Abnormal affective startle modulation in individuals with psychogenic [corrected] movement disorder.
      ].
      Building from this, the mechanistic relevance of alexithymia to the development of functional symptoms might relate to the failure to correctly recognise autonomic arousal during a precipitating event (or chronically) as anxiety, but rather incorrectly interpreted as symptoms of physical illness [
      • Drane D.L.
      • Fani N.
      • Hallett M.
      • Khalsa S.S.
      • Perez D.L.
      • Roberts N.A.
      A framework for understanding the pathophysiology of functional neurological disorder.
      ,
      • Indranada A.M.
      • Mullen S.A.
      • Duncan R.
      • Berlowitz D.J.
      • Kanaan R.A.A.
      The association of panic and hyperventilation with psychogenic non-epileptic seizures: a systematic review and meta-analysis.
      ]. A vicious cycle of mislabelling and symptom perception may ensue, exacerbated by a narrowed focus of attention, and reduced mental flexibility (also relevant to autistic traits).
      Aberrant emotional processing alongside dysfunctional interoception are important mechanistic factors in FND. Both enhanced and impaired interoception have been reported in ASD, whilst impaired interoception has been strongly correlated with alexithymia [
      • Schauder K.B.
      • Mash L.E.
      • Bryant L.K.
      • Cascio C.J.
      Interoceptive ability and body awareness in autism spectrum disorder.
      ,
      • Fiene L.
      • Brownlow C.
      Investigating interoception and body awareness in adults with and without autism spectrum disorder.
      ,
      • Pollatos O.
      • Carruthers G.
      • Muggleton N.G.
      • Longarzo M.
      • Grossi D.
      • D’olimpio F.
      • et al.
      The relationships between interoception and alexithymic trait. The self-awareness questionnaire in healthy subjects.
      ]. When looking at the relationship between alexithymia and ASD, it is reported as common to, but distinct from ASD itself (and rather it is alexithymia that is more associated socioemotional difficulties common to ASC - the “alexithymia hypothesis”) [
      • Bird G.
      • Cook R.
      Mixed emotions: the contribution of alexithymia to the emotional symptoms of autism.
      ,
      • Cuve H.C.
      • Murphy J.
      • Hobson H.
      • Ichijo E.
      • Catmur C.
      • Bird G.
      Are autistic and alexithymic traits distinct? A factor-analytic and network approach.
      ,
      • Marchesi C.
      • Brusamonti E.
      • Maggini C.
      Are alexithymia, depression, and anxiety distinct constructs in affective disorders?.
      ]. Building on this, when Shah et al. controlled for autistic traits and diagnosis, they reported that alexithymia, rather than autism, was associated with atypical interoception [
      • Shah P.
      • Hall R.
      • Catmur C.
      • Bird G.
      Alexithymia, not autism, is associated with impaired interoception.
      ].
      Jungilligens et al.'s 2022 perspective article relates the theory of constructed emotion to the FND predictive processing framework, [
      • Jungilligens J.
      • Paredes-Echeverri S.
      • Popkirov S.
      • Barrett L.F.
      • Perez D.L.
      A new science of emotion: implications for functional neurological disorder.
      ] where incoming sensory information from the body and world is compared to features that have already been classified (i.e., a prediction/emotion concept) and can be used to give meaning to the current input (constructed emotion). Similar features from the past are pieced together to give meaning to the present by category construction. In FND they propose there is aberrant emotional construction, such that incoming sensory input might match a prediction that does not have emotion content, and a bodily/illness category is constructed (e.g. ‘shaking’). This adds relevance to the role of alexithymia in FND, where non-alexithymics might appropriately use emotion concepts instead bodily and health/illness concepts in moments of arousal.
      Jungilligens et al. also formulate that altered neurodevelopment (as well as adverse experiences) may affect the development of conceptual categories of emotion, as well as impact the ability to update prediction models reliant on emotion concepts, proposing: “Deficits in sensory processing, interoceptive accuracy, biased attention and impairments in motor learning among other constructs limit the use of precision signals and predictive errors to improve future predictions… we speculate that developmentally mediated disruptions in emotion construction play a role in the increased propensity for functional neurological symptoms in these populations.” [
      • Jungilligens J.
      • Paredes-Echeverri S.
      • Popkirov S.
      • Barrett L.F.
      • Perez D.L.
      A new science of emotion: implications for functional neurological disorder.
      ].

      4.5 Limitations

      This study did not seek to independently verify an autism diagnosis but rather to identify traits. This may limit the clinical generalisability of our conclusions. A further limitation is the lack of the control group, and that the AQ positive and negative groups were not matched for age and sex.
      The generalisability of our findings with regards to the FND population may also be limited as by nature of a tertiary specialist centre. Our sample may represent cases more likely to agree with the diagnosis and hence participate in treatment at a specialist centre, they may also be more motivated and engaged in their treatment plans compared to the general FND population. Also, although our referral criteria necessitated an FND diagnosed by a neurologist, we were unable to confirm the criteria used.
      Another limitation is that we were unable to classify groups by FND subtype. Instead we noted the predominant symptom which was decided subjectively from retrospective review of referral letters. The combination of symptom modality experienced by most patients reflects the naturalistic nature of the study but also limits conclusions about motor/sensory/cognitive/PNES FND subtypes.

      5. Conclusion

      In conclusion, we have demonstrated new findings of a high prevalence of autistic traits in FND and have explored the role alexithymia plays in mediating ASD traits and depression. We hypothesise a possible role of interoceptive differences to be relevant in our findings. Future research could explore this role, as well as outcomes for AQ positive patients.

      Declaration of Competing Interest

      On behalf of all authors, the corresponding author states that there is no conflict of interest.

      Appendix A. Supplementary data

      References

        • Bennett K.
        • Diamond C.
        • Hoeritzauer I.
        • Gardiner P.
        • McWhirter L.
        • Carson A.
        • et al.
        A practical review of functional neurological disorder (FND) for the general physician.
        Clin Med (Lond). 2021; 21: 28-36https://doi.org/10.7861/CLINMED.2020-0987
        • Espay A.J.
        • Aybek S.
        • Carson A.
        • Edwards M.J.
        • Goldstein L.H.
        • Hallett M.
        • et al.
        Current concepts in diagnosis and treatment of functional neurological disorders.
        JAMA Neurol. 2018; 75: 1132-1141https://doi.org/10.1001/JAMANEUROL.2018.1264
        • Tian J.
        • Gao X.
        • Yang L.
        Repetitive restricted behaviors in autism spectrum disorder: from mechanism to development of therapeutics.
        Front. Neurosci. 2022; 16https://doi.org/10.3389/FNINS.2022.780407
        • Lai M.C.
        • Baron-Cohen S.
        Identifying the lost generation of adults with autism spectrum conditions.
        Lancet Psychiatry. 2015; 2: 1013-1027https://doi.org/10.1016/S2215-0366(15)00277-1
      1. Autism spectrum quotient (AQ-10) test | Autism spectrum disorder in adults: diagnosis and management | Guidance | NICE n.d. https://www.nice.org.uk/guidance/cg142/resources/autism-spectrum-quotient-aq10-test-143968 (accessed January 6, 2022).

        • Williams Z.J.
        • Gotham K.O.
        Improving the measurement of alexithymia in autistic adults: a psychometric investigation of the 20-item Toronto alexithymia scale and generation of a general alexithymia factor score using item response theory.
        Mol Autism. 2021; 12: 56https://doi.org/10.1186/S13229-021-00463-5
        • Franz M.
        • Popp K.
        • Schaefer R.
        • Sitte W.
        • Schneider C.
        • Hardt J.
        • et al.
        Alexithymia in the German general population.
        Soc. Psychiatry Psychiatr. Epidemiol. 2008; 43: 54-62https://doi.org/10.1007/S00127-007-0265-1
        • Gulpek D.
        • Kelemence Kaplan F.
        • Kesebir S.
        • Bora O.
        Alexithymia in Patients with Conversion Disorder.
        68. 2014: 300-305https://doi.org/10.3109/08039488.2013.814711
        • Carano A.
        • de Berardis D.
        • Gambi F.
        • di Paolo C.
        • Campanella D.
        • Pelusi L.
        • et al.
        Alexithymia and body image in adult outpatients with binge eating disorder.
        Int J Eat Disord. 2006; 39: 332-340https://doi.org/10.1002/EAT.20238
        • Hatta K.
        • Hosozawa M.
        • Tanaka K.
        • Shimizu T.
        Exploring traits of autism and their impact on functional disability in children with somatic symptom disorder.
        J. Autism Dev. Disord. 2019; 49: 729-737https://doi.org/10.1007/s10803-018-3751-2
        • Nimmo-Smith V.
        • Heuvelman H.
        • Dalman C.
        • Lundberg M.
        • Idring S.
        • Carpenter P.
        • et al.
        Anxiety disorders in adults with autism spectrum disorder: a population-based study.
        J. Autism Dev. Disord. 2020; 50: 308-318https://doi.org/10.1007/S10803-019-04234-3/TABLES/3
        • Jester K.A.
        • Londino D.L.
        • Hayman J.
        2.68 Examining the occurrence of conversion disorder diagnoses and asd among adolescents and young adults in the emergency departmenT.
        J. Am. Acad. Child Adolesc. Psychiatry. 2019; 58: S193https://doi.org/10.1016/j.jaac.2019.08.160
        • McWilliams A.
        • Reilly C.
        • Gupta J.
        • Hadji-Michael M.
        • Srinivasan R.
        • Heyman I.
        Autism spectrum disorder in children and young people with non-epileptic seizures.
        Seizure. 2019; 73: 51-55https://doi.org/10.1016/j.seizure.2019.10.022
        • Nisticò V.
        • Goeta D.
        • Iacono A.
        • Tedesco R.
        • Giordano B.
        • Faggioli R.
        • et al.
        Clinical overlap between functional neurological disorders and autism spectrum disorders: a preliminary study.
        Neurol. Sci. 2022; 43: 5067-5073https://doi.org/10.1007/S10072-022-06048-1/FIGURES/1
        • Freedman D.A.
        • Terry D.
        • Enciso L.
        • Trott K.
        • Burch M.
        • Albert D.V.F.
        Brief report: psychogenic nonepileptic events in pediatric patients with autism or intellectual disability.
        J. Autism Dev. Disord. 2022; https://doi.org/10.1007/s10803-022-05479-1
        • Freedman D.
        • Terry D.
        • Enciso L.
        • Trott K.
        • Burch M.
        • Albert D.
        Psychogenic nonepileptic events in pediatric patients with autism.
        Neurology. 2020; 94: 5093
        • Rødgaard E.M.
        • Jensen K.
        • Miskowiak K.W.
        • Mottron L.
        Childhood diagnoses in individuals identified as autistics in adulthood.
        Mol Autism. 2021; 12: 1-7https://doi.org/10.1186/S13229-021-00478-Y/TABLES/1
        • Pun P.
        • Frater J.
        • Broughton M.
        • Dob R.
        • Lehn A.
        Psychological profiles and clinical clusters of patients diagnosed with functional neurological disorder.
        Front. Neurol. 2020; 11: 1222https://doi.org/10.3389/FNEUR.2020.580267/BIBTEX
        • Zdankiewicz-Scigała E.
        • Scigała D.
        • Sikora J.
        • Kwaterniak W.
        • Longobardi C.
        Relationship between interoceptive sensibility and somatoform disorders in adults with autism spectrum traits. The mediating role of alexithymia and emotional dysregulation.
        PLoS One. 2021; 16https://doi.org/10.1371/JOURNAL.PONE.0255460
        • Miersch H.C.
        A retrospective study of 131 patients with psychogenic non-epileptic seizures (PNES): comorbid diagnoses and outcome after inpatient treatment.
        Epilepsia. 2012; 53: 69
        • Taurines R.
        • Segura M.
        • Schecklmann M.
        • Albantakis L.
        • Grünblatt E.
        • Walitza S.
        • et al.
        Altered peripheral BDNF mRNA expression and BDNF protein concentrations in blood of children and adolescents with autism spectrum disorder.
        J. Neural Transm. 2014; 121: 1117-1128https://doi.org/10.1007/s00702-014-1162-x
        • Hannant P.
        • Cassidy S.
        • Tavassoli T.
        • Mann F.
        Sensorimotor difficulties are associated with the severity of autism spectrum conditions.
        Front. Integr. Neurosci. 2016; : 10https://doi.org/10.3389/FNINT.2016.00028
        • Griffiths S.
        • Allison C.
        • Kenny R.
        • Holt R.
        • Smith P.
        • Baron-Cohen S.
        The vulnerability experiences quotient (VEQ): a study of vulnerability, mental health and life satisfaction in autistic adults.
        Autism Res. 2019; 12: 1516-1528https://doi.org/10.1002/AUR.2162
        • Wood E.T.
        • Cummings K.K.
        • Jung J.
        • Patterson G.
        • Okada N.
        • Guo J.
        • et al.
        Sensory over-responsivity is related to GABAergic inhibition in thalamocortical circuits.
        Translational Psychiatry. 2021; 11: 1-10https://doi.org/10.1038/s41398-020-01154-0
        • Ranford J.
        • MacLean J.
        • Alluri P.R.
        • Comeau O.
        • Godena E.
        • Curt LaFrance W.
        • et al.
        Sensory processing difficulties in functional neurological disorder: a possible predisposing vulnerability?.
        Psychosomatics. 2020; 61: 343https://doi.org/10.1016/J.PSYM.2020.02.003
        • Khalsa S.S.
        • Adolphs R.
        • Cameron O.G.
        • Critchley H.D.
        • Davenport P.W.
        • Feinstein J.S.
        • et al.
        Interoception and mental health: a roadmap.
        Biol Psychiatry Cogn Neurosci Neuroimaging. 2018; 3: 501-513https://doi.org/10.1016/J.BPSC.2017.12.004
        • Demartini B.
        • Petrochilos P.
        • Ricciardi L.
        • Price G.
        • Edwards M.J.
        • Joyce E.
        The role of alexithymia in the development of functional motor symptoms (conversion disorder).
        J. Neurol. Neurosurg. Psychiatry. 2014; 85: 1132-1137https://doi.org/10.1136/JNNP-2013-307203
        • Pick S.
        • Goldstein L.H.
        • Perez D.L.
        • Nicholson T.R.
        Emotional processing in functional neurological disorder: a review, biopsychosocial model and research agenda.
        J. Neurol. Neurosurg. Psychiatry. 2019; 90: 704https://doi.org/10.1136/JNNP-2018-319201
        • Schaefer M.
        • Egloff B.
        • Gerlach A.L.
        • Witthöft M.
        Improving heartbeat perception in patients with medically unexplained symptoms reduces symptom distress.
        Biol. Psychol. 2014; 101: 69-76https://doi.org/10.1016/J.BIOPSYCHO.2014.05.012
        • Quadt L.
        • Garfinkel S.N.
        • Mulcahy J.S.
        • Larsson D.E.
        • Silva M.
        • Jones A.-M.
        • et al.
        Interoceptive training to target anxiety in autistic adults (ADIE): A single-center, superiority randomized controlled trial-NC-ND license.
        • Petrochilos P.
        • Elmalem M.S.
        • Patel D.
        • Louissaint H.
        • Hayward K.
        • Ranu J.
        • et al.
        Outcomes of a 5-week individualised MDT outpatient (day-patient) treatment programme for functional neurological symptom disorder (FNSD).
        J. Neurol. 2020; 267: 2655-2666https://doi.org/10.1007/S00415-020-09874-5
        • Petrochilos P.
        • Elmalem M.S.
        • Patel D.
        • Louissaint H.
        • Hayward K.
        • Ranu J.
        • et al.
        Outcomes of a 5-week individualised MDT outpatient (day-patient) treatment programme for functional neurological symptom disorder (FNSD).
        J. Neurol. 2020; 267: 2655-2666https://doi.org/10.1007/S00415-020-09874-5
        • Stone J.
        Functional neurological disorders: the neurological assessment as treatment.
        Stone J Pract Neurol. 2016; 16: 7-17https://doi.org/10.1136/practneurol-2015-001242
        • American Psychiatric Association
        Diagnostic and Statistical Manual of Mental Disorders.
        5th ed. American Psychiatric Press, Inc, Arlington, Virginia2013
      2. Introduction to Mediation, Moderation, and Conditional Process Analysis: A Regression-Based Approach. - PsycNET n.d. https://psycnet.apa.org/record/2013-21121-000 (accessed January 5, 2023).

        • Allison C.
        • Auyeung B.
        • Baron-Cohen S.
        Toward brief “red flags” for autism screening: the short autism spectrum quotient and the short quantitative checklist for autism in toddlers in 1,000 cases and 3,000 controls [corrected].
        J. Am. Acad. Child Adolesc. Psychiatry. 2012; 51: 202-212.e7https://doi.org/10.1016/J.JAAC.2011.11.003
        • Kinnaird E.
        • Stewart C.
        • Tchanturia K.
        Investigating alexithymia in autism: a systematic review and meta-analysis.
        European Psychiatry. 2019; 55: 80https://doi.org/10.1016/J.EURPSY.2018.09.004
        • Hemming L.
        • Haddock G.
        • Shaw J.
        • Pratt D.
        Alexithymia and its associations with depression, suicidality, and aggression: an overview of the literature.
        Front Psychiatry. 2019; 10: 203https://doi.org/10.3389/FPSYT.2019.00203/BIBTEX
      3. The Oxford Handbook of Autism and Co-Occurring Psychiatric Conditions - Google Books n.d. https://www.google.co.uk/books/edition/The_Oxford_Handbook_of_Autism_and_Co_Occ/g5TgDwAAQBAJ?hl=en&gbpv=1&pg=PP1&printsec=frontcover (accessed December 5, 2022).

        • Cassidy S.
        • Au-Yeung S.
        • Robertson A.
        • Cogger-Ward H.
        • Richards G.
        • Allison C.
        • et al.
        Autism and autistic traits in those who died by suicide in England.
        Br. J. Psychiatry. 2022; 221: 683-691https://doi.org/10.1192/BJP.2022.21
        • Booth T.
        • Murray A.L.
        • McKenzie K.
        • Kuenssberg R.
        • O’Donnell M.
        • Burnett H.
        Brief report: an evaluation of the AQ-10 as a brief screening instrument for asd in adults.
        J. Autism Dev. Disord. 2013; 43: 2997-3000https://doi.org/10.1007/S10803-013-1844-5/TABLES/2
        • Ashwood K.L.
        • Gillan N.
        • Horder J.
        • Hayward H.
        • Woodhouse E.
        • McEwen F.S.
        • et al.
        Predicting the diagnosis of autism in adults using the autism-spectrum quotient (AQ) questionnaire.
        Psychol. Med. 2016; 46: 2595https://doi.org/10.1017/S0033291716001082
        • Murray A.L.
        • Allison C.
        • Smith P.L.
        • Baron-Cohen S.
        • Booth T.
        • Auyeung B.
        Investigating diagnostic bias in autism spectrum conditions: an item response theory analysis of sex bias in the AQ-10.
        Autism Res. 2017; 10: 790-800https://doi.org/10.1002/AUR.1724
        • Murray A.L.
        • Booth T.
        • Auyeung B.
        • McKenzie K.
        • Kuenssberg R.
        Investigating sex bias in the AQ-10: a replication study.
        Assessment. 2019; 26: 1474-1479https://doi.org/10.1177/1073191117733548/ASSET/IMAGES/LARGE/10.1177_1073191117733548-FIG1.JPEG
        • Jungilligens J.
        • Paredes-Echeverri S.
        • Popkirov S.
        • Barrett L.F.
        • Perez D.L.
        A new science of emotion: implications for functional neurological disorder.
        Brain. 2022; 145: 2648-2663https://doi.org/10.1093/BRAIN/AWAC204
        • Goldstein L.H.
        • Mellers J.D.C.
        Ictal symptoms of anxiety, avoidance behaviour, and dissociation in patients with dissociative seizures.
        J. Neurol. Neurosurg. Psychiatry. 2006; 77: 616-621https://doi.org/10.1136/JNNP.2005.066878
        • Sojka P.
        • Bareš M.
        • Kašpárek T.
        • Světlák M.
        Processing of emotion in functional neurological disorder.
        Front Psychiatry. 2018; 9: 479https://doi.org/10.3389/FPSYT.2018.00479/BIBTEX
        • Seignourel P.J.
        • Miller K.
        • Kellison I.
        • Rodriguez R.
        • Fernandez H.H.
        • Bauer R.M.
        • et al.
        Abnormal affective startle modulation in individuals with psychogenic [corrected] movement disorder.
        Mov. Disord. 2007; 22: 1265-1271https://doi.org/10.1002/MDS.21451
        • Drane D.L.
        • Fani N.
        • Hallett M.
        • Khalsa S.S.
        • Perez D.L.
        • Roberts N.A.
        A framework for understanding the pathophysiology of functional neurological disorder.
        CNS Spectr. 2021; 26: 555-561https://doi.org/10.1017/S1092852920001789
        • Indranada A.M.
        • Mullen S.A.
        • Duncan R.
        • Berlowitz D.J.
        • Kanaan R.A.A.
        The association of panic and hyperventilation with psychogenic non-epileptic seizures: a systematic review and meta-analysis.
        Seizure. 2018; 59: 108-115https://doi.org/10.1016/J.SEIZURE.2018.05.007
        • Schauder K.B.
        • Mash L.E.
        • Bryant L.K.
        • Cascio C.J.
        Interoceptive ability and body awareness in autism spectrum disorder.
        J. Exp. Child Psychol. 2015; 131: 193https://doi.org/10.1016/J.JECP.2014.11.002
        • Fiene L.
        • Brownlow C.
        Investigating interoception and body awareness in adults with and without autism spectrum disorder.
        Autism Res. 2015; 8: 709-716https://doi.org/10.1002/AUR.1486
        • Pollatos O.
        • Carruthers G.
        • Muggleton N.G.
        • Longarzo M.
        • Grossi D.
        • D’olimpio F.
        • et al.
        The relationships between interoception and alexithymic trait. The self-awareness questionnaire in healthy subjects.
        Frontiers in Psychology | WwwFrontiersinOrg. 2015; 1: 1149https://doi.org/10.3389/fpsyg.2015.01149
        • Bird G.
        • Cook R.
        Mixed emotions: the contribution of alexithymia to the emotional symptoms of autism.
        Translational Psychiatry. 2013; 3 (e285–e285)https://doi.org/10.1038/tp.2013.61
        • Cuve H.C.
        • Murphy J.
        • Hobson H.
        • Ichijo E.
        • Catmur C.
        • Bird G.
        Are autistic and alexithymic traits distinct? A factor-analytic and network approach.
        J. Autism Dev. Disord. 2021; : 1-16https://doi.org/10.1007/S10803-021-05094-6/FIGURES/5
        • Marchesi C.
        • Brusamonti E.
        • Maggini C.
        Are alexithymia, depression, and anxiety distinct constructs in affective disorders?.
        J. Psychosom. Res. 2000; 49: 43-49https://doi.org/10.1016/S0022-3999(00)00084-2
        • Shah P.
        • Hall R.
        • Catmur C.
        • Bird G.
        Alexithymia, not autism, is associated with impaired interoception.
        Cortex. 2016; 81: 215-220https://doi.org/10.1016/j.cortex.2016.03.021